Optimized Anti-CD30 Antibodies

Details for Australian Patent Application No. 2011202115 (hide)

Owner Xencor, Inc.

Inventors Lazar, Gregory Alan; Desjarlais, John R.; Hammond, Philip W.; Carmichael, David F.; Chen, Bao-lu; Chu, Seung Y.; Karki, Sher Bahadur

Agent Davies Collison Cave

Pub. Number AU-A-2011202115

Parent 2006302254

Filing date 9 May 2011

Wipo publication date 26 May 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

26 May 2011 Application Open to Public Inspection

  Published as AU-A-2011202115

26 May 2011 Complete Application Filed

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202116-Process using rare earths to remove oxyanions from aqueous streams

2011202114-A method and apparatus for assisting with building construction